当不推荐使用减毒活流感疫苗时儿童流感疫苗接种率下降
研究利用美国宾夕法尼亚州中部一家学术性初级保健儿科中心的队列与横断面数据,比较2015-16和2016-17流感季节2-17岁儿童疫苗接种率。结果显示,在不推荐使用减毒活流感疫苗(LAIV)的2016-17季节,季末接种率较低(50.4% vs 52.0%,p=0.03),且前一年接种LAIV者重复接种的比值比较低(OR 1.32,95%CI 1.15-1.52,比较对象为前一年接种IIV者)。
要点
- 2016-17季不推荐LAIV时,季末接种率50.4% vs 2015-16季52.0%(p=0.03)。
- 2015-16季接种IIV者较接种LAIV者,2016-17季重复接种OR 1.32(95%CI 1.15-1.52)。
- 早期接种率在不推荐LAIV季较高(24.7% vs 22.8%,p=0.004)。
核心结论
- 2016-17季不推荐LAIV时季末疫苗接种率较低,尤其在前一年接种LAIV的儿童中。
- 2016-17季LAIV不可获得可能影响了流感疫苗接种的便利性和感知有效性,这两个因素可能影响儿科人群的疫苗摄取。
研究设计与样本
- 研究使用美国宾夕法尼亚州中部一家学术性初级保健儿科中心的队列和横断面数据,该中心服务约12,500名患者。
- 记录2015-16和2016-17流感季节2-17岁个体早期(11月1日前)和季末(3月1日前)疫苗接种率。
- 记录2015-16季至2016-17季重复接种率(一个季节接种流感疫苗的儿童在下一季节也接种的百分比)。
- 采用逻辑回归模型调整种族、民族、年龄、保险类型和接种疫苗类型,以识别重复接种的预测因素。
主要发现
- 无LAIV的2016-17季早期接种率显著较高(24.7% vs 22.8%,p=0.004),但季末接种率较低(50.4% vs 52.0%,p=0.03)。
- 调整协变量后,2015-16季接种IIV者较接种LAIV者,2016-17季重复接种的比值比为OR 1.32(95%CI 1.15-1.52)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2016 the Centers for Disease Control and Prevention (CDC) recommended against using the live attenuated influenza vaccine (LAIV) for the 2016-2017 influenza season. This recommendation is potentially important for vaccination rates because perceived effectiveness and ease of administration are among the primary determinants of families decisions to vaccinate their children. This investigation sought to determine whether rates of pediatric influenza vaccination changed in a season when the LAIV was not recommended. METHODS: This study used cohort and cross sectional data from an academic primary care pediatric center in central Pennsylvania that serves approximately 12,500 patients. Early season (prior to November 1) and end-of-season (prior to March 1) vaccination rates in the 2015-16 and 2016-17 influenza seasons were recorded for individuals 2-17years old. Repeat vaccination rates (percentage of children receiving influenza vaccination in one season who were also vaccinated in the next season) were recorded for the 2015-16 into 2016-17 seasons. A logistic regression model adjusting for race, ethnicity, age, insurance type and type of vaccination received was employed to identify predictors of repeat vaccination. RESULTS: In the absence of LAIV (2016-17) early vaccination rates were significantly higher (24.7% vs 22.8%, p=0.004), but end-of-season rates were lower (50.4% vs 52.0%, p=0.03) than when LAIV was offered (2015-16). After adjusting for covariates, those who had received IIV in the 2015-16 season had higher odds (OR 1.32, 95% CI, 1.15-1.52) of getting a repeat vaccination in the 2016-17 season, compared with those who had received LAIV in the 2015-16 season. CONCLUSIONS: End-of-season vaccination rates were lower in 2016-17 when LAIV was not recommended, particularly among children who received LAIV in the preceding year. Unavailability of LAIV in the 2016-17 season may have impacted influenza vaccination convenience and perceived effectiveness, two factors which could influence vaccine uptake in pediatric populations.
引用
- Fogel B, Hicks S. Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended. Vaccine. 2017. PMID: 28760609. doi:10.1016/j.vaccine.2017.07.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。